EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Adherence to Antithrombotic and Lipid Lowering Therapy and Clinical Outcomes in Patients with Lower Extremity Peripheral Arterial Disease: A Nationwide Nested Case Control Study

Mette Søgaard, Flemming Skjøth, Christian-Alexander Behrendt, Chalotte W Nicolajsen, Anette A Højen, Marie Dahl, Christian N Petersen, Marie Ørskov

European Journal of Vascular and Endovascular Surgery · 2025

DOI: 10.1016/j.ejvs.2025.09.015 ↗

Kurz gefasst

Fachartikel in der Zeitschrift European Journal of Vascular and Endovascular Surgery, 2025. Verfasst von Mette Søgaard und 7 weiteren Autor:innen. Beteiligte Einrichtung: Danish Centre for Health Services Research, Department of Clinical Medicine, Aalborg University and Aalborg University Hospital, Aalborg, Denmark; Ce…. Hauptthemen laut MEDLINE: Peripheral Arterial Disease, Fibrinolytic Agents, Lower Extremity, Hypolipidemic Agents. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 43 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Karen Elise Jensen Foundation.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

OBJECTIVE: Guidelines recommend lifelong antithrombotic and lipid lowering therapy to reduce adverse events in symptomatic lower extremity peripheral arterial disease (PAD), yet adherence remains suboptimal. This study investigated the impact of adherence to antithrombotic and lipid lowering therapy on limb and mortality related outcomes. METHODS: In this nationwide, nested case control study using Danish nationwide registries, all patients aged ≥ 40 years with a first symptomatic PAD diagnosis from 2007 - 2021 were identified. Three nested case control analyses were conducted for major amputation, major adverse cardiovascular events (MACEs), and all cause death, matching controls by age, sex, and time since index diagnosis. Adherence was estimated by the proportion of days covered (PDC) in the year before the event. Conditional logistic regression was used to calculate adjusted odds ratios (aORs) and 95% confidence intervals (CIs), adjusting for frailty, comorbidities, and medication use. RESULTS: Among 85 292 patients, there were 4 288 cases of major amputation (median age 73 years; women 36.2%) matched to 17 152 controls, 9 145 cases with MACEs (median age 74 years; women 43.8%) matched to 36 580 controls, and 41 331 deaths (median age 79 years; women 43.6%) matched to 165 324 controls. PDC ranged from 62.6% for major amputations to 71.5% for all cause death. Adherence statistically significantly reduced the risk of major amputation (aOR 0.56, 95% CI 0.51 - 0.62), MACE (aOR 0.79, 95% CI 0.75 - 0.84), and death (aOR 0.78, 95% CI 0.75 - 0.80). Current therapy use on the index date also reduced risk across all outcomes, but discontinuing lipid lowering therapy negated the benefit. CONCLUSION: Although adherence to antithrombotic and lipid lowering therapy significantly reduced limb and mortality related outcomes in patients with symptomatic PAD, the PDC remained modest, emphasising the need for strategies to improve long term adherence in this high risk population.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Peripheral Arterial DiseaseFibrinolytic AgentsLower ExtremityHypolipidemic AgentsHumansFemaleMaleAgedAmputation, SurgicalCase-Control StudiesMiddle AgedDenmarkRegistriesAged, 80 and overTreatment OutcomeRisk FactorsGuideline Adherence

Stichwörter der Autor:innen

AdherenceCardiovascular diseaseOutcomesPeripheral arterial diseasePrognosisSecondary prevention

Substanzen

Fibrinolytic AgentsHypolipidemic Agents

Autor:innen und Institutionen

  • Danish Centre for Health Services Research, Department of Clinical Medicine, Aalborg University and Aalborg University Hospital, Aalborg, Denmark; Centre for General Practice, Aalborg University, Aalborg, Denmark. Elect…
  • Research Support Unit, Lillebaelt Hospital, University Hospitals of Southern Denmark, Vejle, Denmark; Institute of Regional Health Research, University of Southern Denmark, Vejle, Denmark.
  • Department of Vascular and Endovascular Surgery, Asklepios Clinic Wandsbek, Asklepios Medical School, Hamburg, Germany; Brandenburg Medical School Theodor Fontane, Neuruppin, Germany.
  • Department of Vascular Surgery, Viborg Regional Hospital, Viborg, Denmark.
  • Danish Centre for Health Services Research, Department of Clinical Medicine, Aalborg University and Aalborg University Hospital, Aalborg, Denmark.
  • Department of Vascular Surgery, Viborg Regional Hospital, Viborg, Denmark; Department of Clinical Medicine, Aarhus University, Aarhus, Denmark; Research Unit of Cardiac, Thoracic, and Vascular Surgery, Department of Cli…

Förderung

  • Karen Elise Jensen Foundation

Zitieren

APA

Søgaard, M., Skjøth, F., Behrendt, C. A., Nicolajsen, C. W., Højen, A. A., Dahl, M., Petersen, C. N., & Ørskov, M. (2025). Adherence to Antithrombotic and Lipid Lowering Therapy and Clinical Outcomes in Patients with Lower Extremity Peripheral Arterial Disease: A Nationwide Nested Case Control Study. European Journal of Vascular and Endovascular Surgery. https://doi.org/10.1016/j.ejvs.2025.09.015

Vancouver

Søgaard M, Skjøth F, Behrendt CA, Nicolajsen CW, Højen AA, Dahl M, et al. Adherence to Antithrombotic and Lipid Lowering Therapy and Clinical Outcomes in Patients with Lower Extremity Peripheral Arterial Disease: A Nationwide Nested Case Control Study. European Journal of Vascular and Endovascular Surgery. 2025. doi:10.1016/j.ejvs.2025.09.015

BibTeX
@article{Sgaard2025,
  author = {Søgaard, Mette and Skjøth, Flemming and Behrendt, Christian-Alexander and Nicolajsen, Chalotte W and Højen, Anette A and Dahl, Marie and Petersen, Christian N and Ørskov, Marie},
  title = {Adherence to Antithrombotic and Lipid Lowering Therapy and Clinical Outcomes in Patients with Lower Extremity Peripheral Arterial Disease: A Nationwide Nested Case Control Study},
  journal = {European Journal of Vascular and Endovascular Surgery},
  year = {2025},
  doi = {10.1016/j.ejvs.2025.09.015}
}
Kostenlos starten →